No Result
View All Result
Saturday, March 6, 2021
Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish
Near future
  • Home
  • Tech
  • Medicine
  • Society
  • Environment
  • Spazio
  • Transportation
  • Weather
  • concepts
  • H+
Near future
No Result
View All Result

A breakthrough drug could cure COVID-19 in just five days

An inhaled product that can cure Covid-19 within 3-5 days has passed the Phase 1 study. That's why it can make a difference.

Gianluca Riccio di Gianluca Riccio
February 7 2021
in Medicine
A breakthrough drug could cure COVID-19 in just five days

3D Illustration Concept of Human Respiratory System Lungs Anatomy

Send to FacebookPin on PinterestSend on TwitterSend on Whatsappon Linkedin

It's too early to call it a miracle cure. But if the conclusions of a recent Phase 1 study for a new drug called EXO-CD24 are confirmed in subsequent trials, we may have the first truly revolutionary therapy to cure Covid-19.

This drug to cure Covid-19 would obviously be in addition to the coronavirus vaccines. Drugs that will help prevent severe COVID-19 cases and deaths and even reduce the spread of the disease.

Maybe you are also interested

2-4 million direct and indirect deaths from Covid not counted in Africa

Urban Sun, an "urban sun" to clean up open spaces from Covid

It is the hunt for the universal vaccine against all coronaviruses

We're sending pills into space for longer space missions

Vaccines: very important, but they are not everything

Vaccines can give the immune system a "warning" about the threat it may face (the real virus) but they have some limitations. First of all, they don't work on infected people. Secondly, the supply of vaccines is still limited and vaccinations are not available for anyone who wants one. Finally, there is the threat of mutations coronavirus that could reduce the effect of vaccines on the virus and extend the pandemic.

If EXO-CD24 can actually help most coronavirus patients recover within five days, it won't just help cure Covid-19 and save more lives. It would complement the vaccines and help deal with mutations.

The drug is intended to calm the immune response that can be deadly in Covid-19 (the so-called "cytokine storm") and should have the same effect regardless of how SARS-CoV-2 evolves.

The problem with recovering from Covid-19 is that the immune system can develop an exacerbated reaction in the risk groups, leading to multiple organ failure and death. The phenomenon is called a cytokine storm and is usually fatal.

The experimentation

In Phase 1 at the Ichilov Medical Center in Tel Aviv, EXO-CD24 was shown to be able to cure Covid-19 within 3-5 days in 29 out of 30 patients. All 30 COVID-19 patients, however, recovered after developing moderate to severe.

The hospital that conducted the trial described the success as a "huge step forward", according to Time of Israel.

How EXO-CD24 works

The drug that can cure Covid-19 within 3-5 days is not an antiviral that chases the virus, trying to eliminate it. The immune system can do it by itself: and it is no coincidence that many people can cure Covid-19 even without treatment.

This drug deals with the cytokine storm by preventing overreaction.

The drug uses exosomes, small transporters that can move materials between cells to deliver the CD24 protein directly to the lungs. This is a protein that Professor Nadir Arber has been studying for decades.

Treat Covid-19 within 3-5 days with EXO-CD24
Nadir Arber

“The preparation is inhaled once a day for a few minutes, for five days,” says Arber. “The preparation is directed directly to the heart of the storm (the lungs). For this, unlike other formulas that selectively retain a certain cytokine, or operate widely but cause many serious side effects, EXO-CD24 is administered locally, works widely and without unwanted effects ".

Next steps

This protein is found on the surface of cells and has a well-known and important role in regulating the immune system.

Shiran Shapira, researcher and co-author of the research on EXO-CD24

The drug will move on to later stages of the research, which should provide more data on efficacy and safety.

Like vaccines, EXO-CD24 will need to receive emergency clearance before it can be used to treat Covid-19.

tags: Coronavirusdrugs
Previous post

An artificial aorta can reduce the need for a heart transplant

Next article

Elon Musk at the Air Force: "human fighters are over"

Gianluca Riccio

Gianluca Riccio

Gianluca Riccio, born in 1975, is the creative director of an advertising agency, copywriter and journalist. He is affiliated with Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists. Since 2006 he directs Futuroprossimo.it, the Italian resource of Futurology.

Maybe you are also interested in:

plant against dizziness
Medicine

An implant in the inner ear restores balance to those suffering from vertigo

A team reprograms the cartilage that produces its own anti-inflammatories
Medicine

A team reprograms the cartilage that produces its own anti-inflammatories

A Yale team repairs the spinal cord with patient stem cells
Medicine

A Yale team repairs the spinal cord with patient stem cells

Next article
Elon Musk at the Air Force: "human fighters are over"

Elon Musk at the Air Force: "human fighters are over"

We use 6 billion ffp2 masks a day: a team can make roads

We use 6 billion ffp2 masks a day: a team can make roads

Leave a comment Cancel reply

Your email address will not be published.

Collaborate!

We are open to visions about the future. Submit an article, disclose the results of a search or scientific discoveries, shows points of view on a theme, tells about a change.

Contact us
The last
  • Triton 13000/2 Titanic Explorer, the submarine that flies underwaterMarch 6 2021
    A small "bubble" submarine with retractable gull wings is able to "fly" at will under water, from bottom to surface, offering maneuverability and spectacular footage of the depths.
  • Scientists have discovered a mysterious layer in the Earth's coreMarch 5 2021
    A new layer inside the Earth's core shows us new scenarios on its formation and on the geological phenomena taking place before man arrived.
  • 2-4 million direct and indirect deaths from Covid not counted in AfricaMarch 5 2021
    Only 8 countries in Africa officially and unambiguously register their victims: this leads to having to consider very much the deaths from Covid. And it raises a serious alarm.

Most read of the week

  • M1, the huge 165-inch MicroLED TV vanishes into thin air when turned off

    M1, the huge 165-inch MicroLED TV vanishes into thin air when turned off

    67 shares
    Share 26 Tweet 17
  • Scientists levitate a plastic disc using only light

    66 shares
    Share 26 Tweet 16
  • World population growth will stop after centuries

    3134 shares
    Share 1253 Tweet 783
  • V90 Villa Edition, camper with terrace on the second floor

    228 shares
    Share 91 Tweet 57

Futuroprossimo.it is an Italian resource of futurology opened since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.

Tag

Environment Architecture Communication concepts Advice Energy Events Gadgets The future of yesterday The newspaper of tomorrow Medicine Military Weather Robotica Society Spazio Technology transhumanism Transportation Video

Categories

The author

Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.

Collaborate! Are you interested in writing a post on Futuroprossimo? Click here for contacts.

Home / Author / IDEA / archive / Promo on FP

© 2020 Futuroprossimo - Tailored by Be Here

© 2020 Futuroprossimo - Tailored by Be Here

  • Home
  • Contact
  • archive
  • Technology
  • Medicine
  • Transportation
  • Weather
  • Society
  • Environment
  • transhumanism

© 2019 Futuroprossimo - Tailored by To be here

This site uses cookies. By continuing to read it, you consent to their use.